Membrane cholesterol removal and replenishment affect rat and monkey brain monoamine transporters

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuropharmacology

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2018.01.039PMID 29407218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease

  2017influential reference
• Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction

  2017cited by this paper
• Current insights into pathogenesis of Parkinson's disease: Approach to mevalonate pathway and protective role of statins.

  2017cited by this paper
• The Serotonin Transporter and Early Life Stress: Translational Perspectives

  2017cited by this paper
• Effects of diet and insulin on dopamine transporter activity and expression in rat caudate‐putamen, nucleus accumbens, and midbrain

  2017cited by this paper
• The effect of sterol structure upon clathrin-mediated and clathrin-independent endocytosis

  2017cited by this paper
• Confounding of the association between statins and Parkinson disease: systematic review and meta‐analysis

  2017cited by this paper
• Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database

  2017cited by this paper
• Can Cholesterol Metabolism Modulation Affect Brain Function and Behavior?

  2017cited by this paper
• Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi‐site molecular tethering of photoactive cocaine analogs

  2017cited by this paper
• Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains

  2017cited by this paper
• Cyclodextrin-Lipid Complexes: Cavity Size Matters

  2017cited by this paper
• Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction

  2016cited by this paper
• What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?

  2016influential reference
• The effect of prolonged simvastatin application on serotonin uptake, membrane microviscosity and behavioral changes in the animal model.

  2016influential reference
• The role of cholesterol in membrane fusion.

  2016cited by this paper
• Mapping Cholesterol Interaction Sites on Serotonin Transporter through Coarse-Grained Molecular Dynamics

  2016cited by this paper
• X-ray structures and mechanism of the human serotonin transporter

  2016influential reference
• Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains.

  2016cited by this paper
• Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis

  2016cited by this paper
• The lipid habitats of neurotransmitter receptors in brain.

  2016cited by this paper
• Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.

  2015cited by this paper
• Secretory vesicle cholesterol: Correlating lipid domain organization and Ca2+ triggered fusion.

  2015cited by this paper
• Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

  2015cited by this paper
• Cholesterol - A putative endogenous contributor towards Parkinson's disease.

  2015cited by this paper
• Expression of dopamine transporter in the different cerebral regions of methamphetamine-dependent rats

  2015cited by this paper
• A Dualistic Conformational Response to Substrate Binding in the Human Serotonin Transporter Reveals a High Affinity State for Serotonin*

  2015influential reference
• Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants

  2015cited by this paper
• Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

  2015cited by this paper
• Lateral organization, bilayer asymmetry, and inter-leaflet coupling of biological membranes.

  2015cited by this paper
• Neurotransmitter and psychostimulant recognition by the dopamine transporter

  2015cited by this paper
• The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years.

  2014cited by this paper
• The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants

  2014cited by this paper
• Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

  2014cited by this paper
• SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking

  2014cited by this paper
• Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood

  2014cited by this paper
• Cholesterol in brain disease: sometimes determinant and frequently implicated

  2014cited by this paper
• The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.

  2014cited by this paper
• X-ray structure of dopamine transporter elucidates antidepressant mechanism

  2013influential reference
• Effect of cyclodextrin and membrane lipid structure upon cyclodextrin-lipid interaction.

  2013cited by this paper
• Small-scale isolation of synaptic vesicles from mammalian brain

  2013cited by this paper
• Long-term statin use and the risk of Parkinson's disease.

  2013cited by this paper
• Mechanisms of dopamine transporter regulation in normal and disease states.

  2013cited by this paper
• Nonclassical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators, and Partial Substrates

  2013cited by this paper
• Cholesterol Biosynthesis and Homeostasis in Regulation of the Cell Cycle

  2013cited by this paper
• Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.

  2013influential reference
• Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies

  2012cited by this paper
• Importance of cholesterol in dopamine transporter function

  2012influential reference
• Regulation of cholesterol biosynthetic pathway in different regions of the rat central nervous system

  2012cited by this paper
• Prospective study of statin use and risk of Parkinson disease.

  2012cited by this paper
• Cholesterol: Its Regulation and Role in Central Nervous System Disorders

  2012cited by this paper
• Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

  2012cited by this paper
• Cholesterol-Independent Effects of Methyl-β-Cyclodextrin on Chemical Synapses

  2012cited by this paper
• Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease.

  2012influential reference
• The effects of statins on mood: a review of the literature

  2012cited by this paper
• Association of membrane rafts and postsynaptic density: proteomics, biochemical, and ultrastructural analyses

  2011cited by this paper
• Proteins interacting with monoamine transporters: current state and future challenges.

  2011cited by this paper
• VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease

  2011cited by this paper
• Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.

  2011cited by this paper
• SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation

  2011cited by this paper
• Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT

  2011cited by this paper
• Cholesterol reduction impairs exocytosis of synaptic vesicles

  2010cited by this paper
• Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding*

  2010influential reference
• Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study

  2010cited by this paper
• Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment

  2010cited by this paper
• Cholesterol-Dependent Kinase Activity Regulates Transmitter Release from Cerebellar Synapses

  2010cited by this paper
• Rapid substrate‐induced down‐regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens

  2009cited by this paper
• Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3

  2009cited by this paper
• Dopamine transporter relation to levodopa‐derived synaptic dopamine in a rat model of Parkinson’s: an in vivo imaging study

  2009cited by this paper
• A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles

  2009cited by this paper
• Statins and the risk of Parkinson disease: an update on the controversy.

  2009cited by this paper
• Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease.

  2009cited by this paper
• Differential regional effects of methamphetamine on dopamine transport.

  2008cited by this paper
• Phorbol ester induced trafficking‐independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol

  2008cited by this paper
• Labeling of Dopamine Transporter Transmembrane Domain 1 with the Tropane Ligand N-[4-(4-Azido-3-[125I]iodophenyl)butyl]-2β-carbomethoxy-3β-(4-chlorophenyl)tropane Implicates Proximity of Cocaine and Substrate Active Sites

  2008cited by this paper
• Dysregulation of Dopamine Transporter Trafficking and Function after Abstinence from Cocaine Self-Administration in Rats: Evidence for Differential Regulation in Caudate Putamen and Nucleus Accumbens

  2008cited by this paper
• Labeling of Dopamine Transporter Transmembrane Domain 1 with the Tropane Ligand N -[4-(4-Azido-3-[ 125 I]iodophenyl)butyl]-2 (cid:1) -carbomethoxy-3 (cid:1) -(4-chlorophenyl)tropane Implicates Proximity of Cocaine and Substrate Active Sites

  2008cited by this paper
• Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

  2007cited by this paper
• Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration

  2007cited by this paper
• Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.

  2007influential reference
• Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

  2007influential reference
• Ligand Binding and G-protein Coupling of the Serotonin1A Receptor in Cholesterol-enriched Hippocampal Membranes

  2006cited by this paper
• Influence of cholesterol depletion in plasma membrane of rat brain synaptosomes on calcium-dependent and calcium-independent exocytosis.

  2006cited by this paper
• Significance of Sterol Structural Specificity

  2006cited by this paper
• Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease.

  2005cited by this paper
• Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid‐β peptide

  2004influential reference
• Plasma membrane microdomains: organization, function and trafficking.

  2004cited by this paper
• Calorimetric measurement of phospholipid interaction with methyl-beta-cyclodextrin.

  2004cited by this paper
• Partitioning of the Serotonin Transporter into Lipid Microdomains Modulates Transport of Serotonin*

  2004cited by this paper
• Statin effects on cholesterol micro-domains in brain plasma membranes.

  2003cited by this paper
• Structural background of cyclodextrin-protein interactions.

  2003cited by this paper
• Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors

  2003cited by this paper
• Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism.

  2002cited by this paper
• Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

  2001cited by this paper
• Structural Mechanism for Statin Inhibition of HMG-CoA Reductase

  2001cited by this paper
• Drug interactions with the dopamine transporter in cryopreserved human caudate.

  2001influential reference
• Membrane cholesterol modulates serotonin transporter activity.

  2001influential reference
• Mice with Very Low Expression of the Vesicular Monoamine Transporter 2 Gene Survive into Adulthood: Potential Mouse Model for Parkinsonism

  2001cited by this paper
• Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)

  2000cited by this paper
• [HMG-CoA reductase inhibitors].

  1998cited by this paper

• Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerization

  2025cites this paper
• Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases

  2024cites this paper
• Pitavastatin attenuates hypercholesterolemia-induced decline in serotonin transporter availability

  2024cites this paper
• Cholesterol modulation of interactions between psychostimulants and dopamine transporters.

  2024cites this paper
• Atorvastatin differentially regulates the interactions of cocaine and amphetamine with dopamine transporters.

  2022cites this paper
• Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol

  2021cites this paper
• Characterizing the lipid-protein interface of the human serotonin transporter by crosslinking mass spectrometry

  2020cites this paper
• Liquid scintillation analysis: principles and practice

  2020cites this paper
• In-Situ imaging detection of cell membrane and intracellular cholesterol via cascade reactions.

  2019cites this paper
• The Role of Lipids in Parkinson’s Disease

  2019cites this paper
• Estrogenic Compounds: Chemical Characteristics, Detection Methods, Biological and Environmental Effects

  2018cites this paper